Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1210/ENDOCR/BQAA009 | ||||
| Año | 2020 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Spontaneous preterm birth (PTB) is a major obstetrical problem around the globe and the mechanisms leading to PTB are unclear. Recently, changes in the circulating levels of placental extracellular vesicles (EVs) during pregnancy have been associated with various pregnancy complications. However, progress in the field is hindered by the inability to isolate placental EVs from the maternal circulation. A longitudinal study design was used to determine the protein cargo present in circulating placental EVs in maternal plasma of term and PTB across gestation (ie, first, second, and third trimester). Placental-derived EVs were enriched from the total EV population based on their expression of membrane-bound placental alkaline phosphatase (PLAP). A quantitative, information-independent acquisition (sequential windowed acquisition of all theoretical mass spectra [SWATH]) approach identified and quantified the placental EV protein contents. PLAP(+) EVs did not change in characteristics (size, shape, and markers) but did differ in numbers across gestation with low levels in PTB. A comparison analysis between the PLAP(+) EV proteome from term and PTB revealed 96 proteins differing significantly (P < 0.05, false discovery rate 1%) across gestation. Bioinformatics analysis of differentially expressed proteins revealed consistent upregulation of inflammatory pathways in both upregulation of epithelial mesenchymal transition pathways at term and downregulation of coagulation/complement activation in preterm. Characterization of the proteomic profile in PLAP(+) EVs across gestation demonstrates dramatic changes, which might be used to understand the biological process associated with early parturition and develop biomarkers for predicting high-risk status for PTB.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Menon, Ramkumar | - |
Univ Texas Med Branch - Estados Unidos
UT Medical Branch at Galveston - Estados Unidos The University of Texas Medical Branch at Galveston - Estados Unidos |
| 2 | Debnath, Chirantan | - |
Translat Hlth Sci & Technol Inst India - India
Translational Health Science and Technology Institute - India |
| 3 | Lai, Andrew | Hombre |
UNIV QUEENSLAND - Australia
UQ Centre for Clinical Research - Australia |
| 4 | Guanzon, Dominic | Hombre |
UNIV QUEENSLAND - Australia
UQ Centre for Clinical Research - Australia |
| 5 | Bhatnagar, Shinjini | - |
Translat Hlth Sci & Technol Inst India - India
Translational Health Science and Technology Institute - India |
| 6 | Kshetrapal, Pallavi | Mujer |
Translat Hlth Sci & Technol Inst India - India
Translational Health Science and Technology Institute - India |
| 7 | Sheller-Miller, Samantha | Mujer |
Univ Texas Med Branch - Estados Unidos
UT Medical Branch at Galveston - Estados Unidos The University of Texas Medical Branch at Galveston - Estados Unidos |
| 8 | SALOMON-GALLO, CARLOS FRANCISCO | Hombre |
UNIV QUEENSLAND - Australia
Universidad de Concepción - Chile UQ Centre for Clinical Research - Australia |
| 9 | Garbh-Ini Study Team | Corporación |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| National Health and Medical Research Council |
| Bill and Melinda Gates Foundation |
| Lions Medical Research Foundation |
| Department of Biotechnology (DBT), Govt. of India |
| Department of Biotechnology, Ministry of Science and Technology, India |
| Agradecimiento |
|---|
| This work was supported by the Bill and Melinda Gates Foundation to R.M. (PI). C.S. is supported by the Lions Medical Research Foundation, National Health and Medical Research Council Grant 1114013, and by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1170809. The samples were collected under the The Garbh-Ini Study that has been funded by the Department of Biotechnology (DBT), Govt. of India, augmented by Biotechnology Industry Research Assistance Council-All Children Thriving (BIRACACT), India. |
| Financial Support: This work was supported by the Bill and Melinda Gates Foundation to R.M. (PI). C.S. is supported by the Lions Medical Research Foundation, National Health and Medical Research Council Grant 1114013, and by Fondo Nacional de Desarrollo Cientifico y Tecnologico Grant 1170809. The samples were collected under the The Garbh-Ini Study that has been funded by the Department of Biotechnology (DBT), Govt. of India, augmented by Biotechnology Industry Research Assistance Council–All Children Thriving (BIRAC-ACT), India. |